Roche Buys U.S. Biotech Jecure in Race for Liver Disease Drugs Roche Buys U.S. Biotech Jecure in Race for Liver Disease Drugs

Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news